AHA, AHIP OpEd: When your medication costs more than your mortgage
“Prescription drug prices are out of control,” wrote AHA President and CEO Rick Pollack and America’s Health Insurance Plans President and CEO Marilyn Tavenner in a Dec. 31 OpEd in The Hill. “The average annual cost for one specialty medication to treat a chronic condition is now more than what most families earn in a year. Big Pharma could solve the problem by committing to more rational and sustainable pricing models. Instead, for the last year, Big Pharma has chosen to point the finger at everyone else, and their decision to engage in a blame game is a tacit admission that drug prices are, in fact, too high.” To read the full column, click here.
Related News Articles
Headline
The Centers for Medicare & Medicaid Services May 3 announced the opening of the comment period for the Inflation Reduction Act’s Medicare Drug Price…
Headline
The Medicare Hospital Insurance Trust Fund will have sufficient funds to pay full benefits until 2036, according to the latest annual report by the Medicare…
Headline
The Centers for Medicare & Medicaid Services May 3 released a final rule that would allow DACA recipients, young undocumented immigrants authorized to work…
Headline
The departments of Health and Human Services, Labor, and the Treasury May 1 released a new process for resubmitting disputes under the No Surprises Act…
Headline
As part of AHA’s recognition of Mental Health Awareness Month in May, Rebecca Chickey, AHA’s senior director for behavioral health services, writes about the “…
Blog
Language not only describes what we think, but shapes how we think. Many of us remember terms that have fallen out of fashion or even have been deemed…